A detailed history of Vontobel Holding Ltd. transactions in Amgen Inc stock. As of the latest transaction made, Vontobel Holding Ltd. holds 154,451 shares of AMGN stock, worth $44.5 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
154,451
Previous 174,631 11.56%
Holding current value
$44.5 Million
Previous $54.6 Million 8.79%
% of portfolio
0.17%
Previous 0.19%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$309.38 - $337.38 $6.24 Million - $6.81 Million
-20,180 Reduced 11.56%
154,451 $49.8 Million
Q2 2024

Aug 13, 2024

BUY
$262.75 - $319.31 $2.75 Million - $3.34 Million
10,473 Added 6.38%
174,631 $54.6 Million
Q1 2024

May 10, 2024

SELL
$268.87 - $324.56 $27.3 Million - $33 Million
-101,594 Reduced 38.23%
164,158 $46.7 Million
Q4 2023

Jun 03, 2024

BUY
$255.7 - $288.46 $3.62 Million - $4.08 Million
14,139 Added 10.1%
154,093 $44.4 Million
Q4 2023

Jan 29, 2024

BUY
$255.7 - $288.46 $8.2 Million - $9.26 Million
32,085 Added 13.73%
265,752 $76.5 Million
Q3 2023

Jun 03, 2024

SELL
$218.65 - $271.46 $4.17 Million - $5.18 Million
-19,074 Reduced 11.99%
139,954 $37.6 Million
Q3 2023

Oct 10, 2023

SELL
$218.65 - $271.46 $7.61 Million - $9.45 Million
-34,802 Reduced 12.96%
233,667 $62.8 Million
Q2 2023

Jun 03, 2024

SELL
$214.27 - $253.37 $1.88 Million - $2.23 Million
-8,791 Reduced 5.24%
159,028 $35.3 Million
Q2 2023

Jul 24, 2023

SELL
$214.27 - $253.37 $3.79 Million - $4.48 Million
-17,676 Reduced 6.18%
268,469 $59.6 Million
Q1 2023

Jun 03, 2024

BUY
$225.79 - $275.2 $826,617 - $1.01 Million
3,661 Added 2.23%
167,819 $40.6 Million
Q1 2023

Apr 12, 2023

BUY
$225.79 - $275.2 $27.6 Million - $33.6 Million
122,262 Added 74.6%
286,145 $69.2 Million
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $1.32 Million - $1.68 Million
5,766 Added 3.65%
163,883 $43 Million
Q3 2022

Nov 04, 2022

BUY
$224.46 - $253.15 $483,711 - $545,538
2,155 Added 1.38%
158,117 $35.6 Million
Q2 2022

Jul 27, 2022

BUY
$230.71 - $256.74 $1.97 Million - $2.19 Million
8,540 Added 5.79%
155,962 $38.3 Million
Q1 2022

May 13, 2022

SELL
$219.27 - $242.57 $1.37 Million - $1.52 Million
-6,248 Reduced 4.07%
147,422 $35.8 Million
Q4 2021

Feb 14, 2022

SELL
$198.88 - $227.6 $3.9 Million - $4.46 Million
-19,608 Reduced 11.32%
153,670 $34.8 Million
Q3 2021

Oct 29, 2021

BUY
$212.27 - $248.7 $165,995 - $194,483
782 Added 0.45%
173,278 $36.8 Million
Q2 2021

Aug 06, 2021

SELL
$233.58 - $259.14 $467 - $518
-2 Reduced -0.0%
172,496 $41.8 Million
Q1 2021

May 11, 2021

SELL
$221.91 - $258.6 $12.6 Million - $14.7 Million
-56,656 Reduced 24.72%
172,498 $42.9 Million
Q4 2020

Feb 12, 2021

BUY
$216.38 - $257.67 $49.6 Million - $59 Million
229,154 New
229,154 $54.4 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $154B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Vontobel Holding Ltd. Portfolio

Follow Vontobel Holding Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.